May 17, 2002
Guidant to Host Investor Briefing at Paris Course on Revascularization

Live Webcast Available

Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that it will host an investor briefing at the EuroPCR (Paris Course on Revascularization). The briefing will take place Friday, May 24, 2002 at 11:00 a.m. Paris time and 5:00 a.m. EDT.

The briefing will be hosted by Guido Neels, president, Europe, Middle East, Africa and Canada, Guidant, and John Capek, Ph.D., president, Vascular Intervention, Guidant. Also in attendance will be a panel of interventional cardiologists including Tony Gershlick, M.D. (Leicester, Britain) and Bill Knopf, M.D. (Atlanta, Ga.).

A live webcast of Guidant's conference call will be accessible through Guidant's website at www.guidant.com/webcast or at CCBN's individual investor center at www.companyboardroom.com. The webcast will be archived on both websites for future on-demand replay.

Guidant Corporation pioneers lifesaving technology, giving an opportunity for better life today to millions of cardiac and vascular patients worldwide. The company, driven by a strong entrepreneurial culture of more than 10,000 employees, develops, manufactures and markets a broad array of products and services that enable less invasive care for some of life's most threatening medical conditions.

System requirements for the webcast include Internet Explorer 5.0 (or higher) or Netscape Navigator 4.0 (or higher). Users also should have the most recent version of Windows Media Player, which can be downloaded for free at http://www.microsoft.com/windows/windowsmedia/en/download/. Users may experience varying levels of performance based on their connection speed, system capabilities and presence of a corporate firewall. To ensure a connection, users should go to the program five to 15 minutes before its start.